Postbiotics Inc. (PBI) develops non-prescription, scientifically proven, bioactive health solutions targeting age-related conditions. PBI researches postbiotics with benefits originally hoped for, but rarely demonstrated, in probiotics and enzymes. Our current products and robust pipeline support proper nutrition, microbiome balance, neuroprotection, mitochondrial function, healthier skin, and strengthened immunity. PBI’s lead postbiotic, PoZibio®, the next generation of digestive health®, is suitable for use in dietary supplements, functional foods, and medical foods. Developed by Wake Forest University Health Sciences, newly patented PoZibio® has demonstrated efficacy for extending lifespan and healthspan, while mitigating the effects associated with Leaky Gut Syndrome and more severe digestive health conditions.

Postbiotics, Inc.

111 N Chestnut Street, Suite 05

Winston-Salem, NC 27101

Contact: Douglas Lynch, CCO and Co-Founder,